BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

South Korea’s DXVX Inks $220M Global Out-Licensing Deal for mRNA Cancer Vaccine with U.S. Biotech

Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXVX announced that it has entered into a co-developmen...

July 31, 2025 | News

GNT Pharma Receives South Korea’s Green Light to Launch Global Phase 3 Trials for Breakthrough Stroke Drug Nelonemdaz

GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, announced its IND Application to commence Glo...

July 25, 2025 | News

Avantor Expands Regional Footprint with New Office in Suwon, South Korea

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies indust...

July 23, 2025 | News

South Korea Approves Clinical Trial of DeepQure’s HyperQure™ System for Atrial Fibrillation

DeepQure announced that South Korea's Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of HyperQure™ RDM System, the c...

July 21, 2025 | News

GC Biopharma Secures Vietnam Approval for Antibiotic-Free Varicella Vaccine BARYCELA

GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from th...

July 18, 2025 | News

SK bioscience Pioneers Korea’s First Adjuvanted Flu Vaccine with IND Filing for NBP607B

Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant Interim results from the Phase 1/2...

July 18, 2025 | News

SN BioScience’s Anticancer Candidate SNB-101 Selected for Korea’s 2025 National Drug Development Programme

SN BioScience announced that its anticancer candidate SNB-101 has been selected as a clinical-stage project under the 2025 Korea Drug Development Project, ...

July 17, 2025 | News

Illimis Therapeutics Raises Series B to Advance GAIA Platform for Alzheimer’s and Immune Disorders

The Series B round saw strong participation from both existing and new investors, demonstrating high industry confidence in Illimis Therapeutics' visi...

July 15, 2025 | News

Lunit Partners with Microsoft to Scale AI-Powered Cancer Diagnostics Globally

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, announced a collaboration with Microsoft to accelerate the deliver...

July 03, 2025 | News

Seegene Launches STAgora™ to Deliver Real-Time Infectious Disease Intelligence and Predictive Insights

Real-time analytics that empower clinical decision-making and pandemic preparedness Global unveiling at ADLM 2025 in Chicago to initiate business p...

July 02, 2025 | News

LUCA AICELL Launches Drug-Free Nasal Spray to Shield Against COVID-19, Influenza, and Mycoplasma Pneumonia

As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, non-pharmaceutical prevention optio...

June 30, 2025 | News

Quanterix Expands Global Reach with South Korea Approval for HD-X Simoa Immunoassay Analyzer

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X ...

June 26, 2025 | News

Novogene Establishes Korean Subsidiary to Strengthen Multi-Omics Innovation and Local Collaboration

Novogene, a global leader in next-generation sequencing (NGS) and multi-omics solutions, today announced the establishment ofNovogene Korea ...

June 23, 2025 | News

SHP Forges Strategic South Korea Ties to Drive AI-Led Innovation in Primary Care

The 10th Asia Pacific Primary Care Research Conference (APPCRC) 2025 commenced at the Academia, SGH Campus, was jointly hosted by SingHealth Po...

June 19, 2025 | News

Stay Connected